Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05396950
Other study ID # UTN: U1111-1278-1680
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 2024
Est. completion date July 2026

Study information

Verified date May 2024
Source Waikato Hospital
Contact Michael Jameson, FRACP
Phone +64 7 839 8899
Email Michael.jameson@waikatodhb.health.nz
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A phase II trial to determine the proportion of patients where the use of continuous positive airway pressure (CPAP) results in a superior radiation plan compared to standard planning procedures. The rationale for using CPAP with radiotherapy is based on its ability to increase the tidal volume, flatten the diaphragm thus reducing respiratory excursions.The resultant lung hyperinflation and reduced respiratory excursions can be harnessed for radiotherapy purposes by: 1. Displacing the heart away from the radiotherapy field 2. Reducing the volume of functional lung irradiated 3. Reducing the radiotherapy target motion CPAP has been shown to be superior to free breathing radiotherapy (RT), however it remains unclear how much benefit it confers vs other motion management adjuncts such as deep inspiration breath hold (DIBH) or 4-DCT.


Description:

PRIMARY OBJECTIVE: To determine the proportion of patients where the use of CPAP results in a superior radiation plan compared to standard planning procedures in each patient cohort SECONDARY OBJECTIVES To determine: - Impact of CPAP on treatment delivery time; - Impact of CPAP on total lung volume; - CPAP compliance; - Patient experience; Breast-specific: • Comparison of organ at risk (OAR) dose constraints between CPAP and deep DIBH) SABR-specific: - Internal target volume (ITV) reduction; - OAR dose constraints between CPAP and standard planning procedures. Breast cancer patients will undergo normal free breathing and DIBH radiotherapy planning scans. An additional scan with CPAP will be done for the purpose of the study. Radiotherapy plans will be produced on both the DIBH and CPAP planning scans. The planning scan with the best dosimetry will be chosen for treatment. If CPAP has a better radiation plan, then the patient will have CPAP administered during their daily RT. The DIBH plans for each patient, will serve as controls SABR patients will undergo the standard 4-D or breath hold CT and then CPAP CT for the purpose of the study. Respiratory movements will be monitored by Varian RPM system. Radiotherapy plans will be produced from the standard CT and the CPAP CT for comparison. Patients will be treated on the best plan The trial aim to recruit 70 patients with invasive carcinoma of the breast undergoing adjuvant radiotherapy that includes breast/chest-wall plus regional lymph nodes, and a convenient sample size of those undergoing SABR to lung or liver


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 70
Est. completion date July 2026
Est. primary completion date July 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Any patient with pathologically-confirmed invasive breast cancer and planned for adjuvant radiotherapy to the breast or chest-wall with regional lymph node coverage - Any patient deemed suitable for lung or liver SABR as per departmental guidelines - Must have signed written informed consent Exclusion Criteria: - Cannot tolerate CPAP e.g due to severe claustrophobia - Re-irradiation

Study Design


Related Conditions & MeSH terms


Intervention

Device:
CPAP
CPAP in conjunction with radiotherapy

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Waikato Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Radiotherapy Plan Selection To determine the proportion of patients where the use of continuous positive airway pressure (CPAP) results in a superior radiation plan compared to standard planning procedures in each patient cohort 6-12 months
Secondary Organ at Risk Dose Constraints Comparison of organ at risk dose constraints between CPAP assisted and standard RT plans
Breast-specific:
A comparison of OAR dose constraints in CPAP vs DIBH including:
Mean Heart Dose, V20Gy heart
Ipsilateral lung V16Gy and V5Gy SABR-Specific
A comparison of OAR dose constraints in CPAP vs DIBH including:
Lung V20Gy, Mean Lung Dose
Heart V40Gy, Mean heart Dose
Liver V15Gy, Mean liver Dose, Liver -GTV
6-12 months
Secondary Compliance and Tolerability Assessment of compliance with CPAP as well as documentation of patient experiences
• Patient experience as documented on a questionnaire after planning CT and on the last week of treatment
6-12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients